Hacked by islam_Bey imhatimi.org

Carborundum Universal Ltd has informed BSE that the Compensation & Nomination Committee on April 30, 2008, approved further grant of 12,400 options under the “Carborundum Universal Ltd Employee Stock Option Scheme 2007″ at an exercise price of Rs 118.05/- being the closing price on National Stock Exchange (where there was highest trading volume) as on April 29, 2008. All other terms and conditions of the options now granted are similar to the options granted earlier.

Carborundum Universal Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 30, 2008, inter alia to transact the following:

1. To approve the audited financial results of the Company for the financial year ended March 31, 2008.

2. To consider recommending a dividend for the financial year ended March 31, 2008.

Carborundum Universal Ltd has informed BSE that the members of the Company by way of Postal Ballot, have passed the following resolution, with requisite majority:

- Amendment in the Clause III of the (Objects Clause) of the Memorandum of Association of the Company by inserting the following as sub-clauses 2L and 2M:

“2L. To manufacture, sell, trade and otherwise deal in products of all kinds and descriptions capable of being used in healthcare / medicare industry (including bio medical devices, bio ceramic products, resin based products and nano material products) and also carry out bio-medical and related research both for in-house needs and also on a commercial scale.

2M. To manufacture, sell, trade and otherwise deal in corrosion resisting materials such as resin cements (including alkali and acid resisting cements), corrosion resisting products and chemicals, specialty chemicals, and anticorrosive products (including mastics, polymer concrete and ucrete), fibre reinforced plastic products, construction chemicals and other related and allied products and services connected therewith.”

Carborundum Universal Ltd has informed BSE that the shareholders of the Company, will consider to approve, by way of Postal Ballot the special resolution to amend Clause III of the (Objects Clause) of the Memorandum of Association of the Company by inserting the following as sub-clauses 2L and 2M:

“2L. To manufacture, sell, trade and otherwise deal in products of all kinds and descriptions capable of being used in healthcare / medicare industry (including bio medical devices, bio ceramic products, resin based products and nano material products) and also carry out bio-medical and related research both for in-house needs and also on a commercial scale.

2M. To manufacture, sell, trade and otherwise deal in corrosion resisting materials such as resin cements (including alkali and acid resisting cements), corrosion resisting products and chemicals, specialty chemicals, and anticorrosive products (including mastics, polymer concrete and ucrete), fibre reinforced plastic products, construction chemicals and other related and allied products and services connected therewith.”

The Board of Directors has appointed Mr. R Sridharan of R Sridharan & Associates, Company Secretaries, as the Scrutinizer for conducting the Postal Ballot in a fair and transparent manner.

The Postal Ballot form duly completed should reach the Scrutinizer on or before close of working hours on March 07, 2008. The Scrutinizer will submit his report to Chairman or Managing Director of the Company after completing scrutiny of the postal ballot. The results of the postal ballot will be announced by the Chairman or the Managing Director of the Company on March 10, 2008.